Schwabe Pharma Group One of the leading global players in the field of phytomedicines Schwabe Pharma UK is part of the Dr. Willmar Schwabe Group, which includes Schwabe Pharmaceuticals, one of the leading global players in the field of phytomedicines. The group has a number of companies in its native Germany, as well as having a number of subsidiaries and joint ventures across the world. Schwabe offers a wide range of products The group offers a wide range of products, including ethical and over the counter (OTC) phytopharmaceuticals for CNS, cardiovascular, urological and respiratory tract applications, synthetic derivatives for specialised therapeutic areas and dietary supplements. The company is driven by an intensive research and development process which has led to many exciting innovations and new products. This is backed up by state-of-the-art manufacturing and its strong global marketing presence. Adhering to the high standards required by licensing authorities The Schwabe Group is currently expanding its marketing activities in all five continents, including the UK, to meet the challenge of international competition. The group’s determination to adhere to the high standards required by licensing authorities, from pharmaceutical quality through pre-clinical and clinical documentation to product manufacturing, is an essential element in this expansion. Following this philosophy, Schwabe has achieved more than 800 drug registrations in over 60 countries. The company has also established teams of qualified medical representatives who are competent partners for doctors and pharmacists. Founded on the ability to act rapidly to market demands thanks to a network of partners, the company’s share in the European, Asian and American markets has been increasing since the 1980’s. International business represents over 45% of the total group turnover. The Schwabe Group is building on this development by intensifying efforts to provide innovative high-quality phytomedical products for the 21st century.
